NCT06510634Enrolling by invitation
Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion
Effectiveness and Safety of Endovascular Treatment vs. Best Medical Treatment in Patients With Vertebrobasilar Artery Occlusion Presenting Beyond 24 Hours of Last Known Well：a Prospective, Multicenter Registry Study
Source: ClinicalTrials.gov · Last updated 28 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Endovascular thrombectomy (EVT) for posterior circulation occlusion is generally performed within a window of less than 24 hours from the time the patient was last known well (LKW). The efficacy and safety of EVT beyond the 24-hour window remain uncertain.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 236 (estimated)
- First submitted
- 14 Jul 2024
- Start date
- 1 Jun 2019
- Primary completion date
- 1 Apr 2024
- Lead sponsor
- Tianjin Huanhu Hospital
- Diseases
- Stroke
- NCT number
- NCT06510634
What you commit to
- Study type: Observational
- Planned participants: 236
- From 1 Jun 2019 to the primary completion date, 1 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- neuroimaging evidence of cerebral hemorrhage on presentation;
- serious, advanced, or terminal illness.
Other
- lack of follow up information on outcomes at 90 days
Who the study is looking for
- age≥18 years.;
- blockage in the vertebrobasilar artery, including the vertebral artery or basilar artery, determined using computed tomographic angiography (CTA)/ magnetic resonance angiography (MRA)/digital subtraction angiography (DSA);
- VBAO occurrence more than 24 hours from LKW;
- none to mild premorbid disability defined by modified Rankin Scale (mRS) score ≤2;
- informed consent before enrollment in the clinical trials.
Age in the registry: 18 years to 90 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tianjin Huanhu Hospital Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.